LABORATORY CORP AMER HLDGS's ticker is and the CUSIP is 50540RAG7. A total of 12 filers reported holding LABORATORY CORP AMER HLDGS in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,665,000 | -26.2% | 12,578,000 | -21.2% | 1.03% | -23.9% |
| Q3 2016 | $29,372,000 | -58.6% | 15,963,000 | -60.8% | 1.36% | -58.8% |
| Q2 2016 | $70,981,000 | -17.3% | 40,705,000 | -25.6% | 3.30% | -18.5% |
| Q1 2016 | $85,829,000 | -10.9% | 54,710,000 | -5.6% | 4.05% | -10.5% |
| Q4 2015 | $96,314,000 | +11.0% | 57,975,000 | -2.5% | 4.52% | +12.8% |
| Q3 2015 | $86,745,000 | -12.0% | 59,465,000 | -1.7% | 4.01% | -3.7% |
| Q2 2015 | $98,558,000 | -3.8% | 60,465,000 | 0.0% | 4.16% | -14.2% |
| Q1 2015 | $102,488,000 | -8.7% | 60,465,000 | -21.8% | 4.85% | +5.9% |
| Q4 2014 | $112,218,000 | +56.1% | 77,344,000 | +46.6% | 4.58% | +64.2% |
| Q3 2014 | $71,893,000 | -0.8% | 52,742,000 | -0.1% | 2.79% | -2.7% |
| Q2 2014 | $72,488,000 | +2.5% | 52,807,000 | -1.3% | 2.87% | +15.9% |
| Q1 2014 | $70,750,000 | +39.7% | 53,477,000 | +30.1% | 2.47% | +35.9% |
| Q4 2013 | $50,629,000 | +157.8% | 41,095,000 | +178.9% | 1.82% | +175.9% |
| Q3 2013 | $19,638,000 | +47.5% | 14,735,000 | +48.7% | 0.66% | +67.9% |
| Q2 2013 | $13,317,000 | – | 9,910,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 77,344,000 | $112,218,000 | 4.58% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 9,350,000 | $13,505,000 | 1.37% |
| SSI INVESTMENT MANAGEMENT LLC | 667,000 | $963,000 | 0.10% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 1,753,000 | $2,538,000 | 0.04% |
| THRIVENT FINANCIAL FOR LUTHERANS | 3,815,000 | $5,520,000 | 0.03% |
| Jefferies Group LLC | 1,855,000 | $2,679,000 | 0.02% |
| Calamos Advisors LLC | 1,305,000 | $1,888,000 | 0.01% |
| AEGON USA Investment Management, LLC | 1,036,000 | $1,496,000 | 0.01% |
| Invesco Ltd. | 9,585,000 | $13,844,000 | 0.01% |
| RAYMOND JAMES & ASSOCIATES | 300,000 | $435,000 | 0.00% |